September 19, 2024 Federal Reserve’s Aggressive Move Hints At Bold Economic Strategy
September 11, 2024 Top Stocks For Smart Investment Choices
September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
Selling Amazon On Recession Risks (Downgrade)
Amazon: See The Company From A Different Perspective
Amazon: Intact Dual Market Leadership
Amazon: Don’t Underestimate The Potential Of AWS To Drive The Stock Higher
Apple: The Real Boost Behind Vision Pro And AI Phones
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
BioNTech (BNTX) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: September 20, 2024 (23:16)
Sector: HealthcareThe share price of BioNTech SE (BNTX) now
News Impact Analyzer
Full report|
This Week
|
Bullish | Impact: 5 | News: 1 (1/0/0) |
|
Previous Week
|
Bullish | Impact: 5 | News: 1 (1/0/0) |
|
Two Weeks Ago
|
Bullish | Impact: 5 | News: 1 (1/0/0) |
|
Three Weeks Ago
|
Bullish | Impact: 5 | News: 1 (1/0/0) |
Analyzing the Most Important BNTX news
BioNTech Surges on Promising Cancer Drug Partnership with Biotheus
Summit Therapeutics Shakes Market, BioNTech Surges with Keytruda Rival
Tempus AI and BioNTech Join Forces to Boost Oncology Research
Historical and forecast chart of BioNTech stock
The chart below shows the historical price of BioNTech stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BioNTech stock price can be found in the table below.
Long-term forecasts by years.
Comprehensive Analysis of BioNTech (BNTX) Stock Market Performance
Our multifaceted analysis of BioNTech's stock market is grounded in the company's key news stories, insights from reputable analysts, as well as mathematical and technical evaluations. Taking into account assessments from each of these aspects in real-time helps us address the most crucial questions for investors in the most objective way possible:
- When should I take profit in BioNTech stock?
- When should I record a loss on BioNTech stock?
- What are analysts' forecasts for BioNTech stock?
- What is the future of BioNTech stock?
We forecast BioNTech stock performance using neural networks based on historical data on BioNTech stocks.
BioNTech SE News influencing stock rates
As of now, Panda has combed through 4 news items directly related to BNTX from the last 30 days. Out of these, 4 clearly showcase a bullish trend, while 0 display bearish tendencies, and 0 events are neutral.
Based on an analysis of the most important news from the last 30 days affecting BNTX shares, it's clear that bullish sentiments are completely overshadowing bearish ones. The impact of positive news is more than five times as dominant as that of negative developments.
The news analyzed fell within the period from Aug 22, 2024, to Sep 17, 2024.
FDA Grants EUA to Moderna and Pfizer's Updated COVID Vaccines Targeting New Variant
FDA Eases Restrictions on BioNTech's Promising Cancer Drug Trial
BioNTech SE is a German biotechnology company that develops and manufactures active immunotherapeutic agents for an individual approach to the treatment of serious diseases. The company is investigating messenger RNA (mRNA) -based drugs for use as individualized immunotherapy for cancer, as vaccines against infectious diseases and as protein replacement therapy for rare diseases, as well as developed cell therapy, new antibodies and small molecules, immunomodulators, as options cancer treatment. The company has developed an intravenous mRNA-based human therapeutic drug to bring individualized mRNA-based cancer immunotherapy to clinical trials and establish its own manufacturing process.
BioNTech daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Sep 22 | 120.30 | 115.10 | 124.92 | 8.53 |
| Sep 23 | 117.27 | 112.48 | 120.65 | 7.26 |
| Sep 24 | 110.66 | 106.27 | 112.18 | 5.56 |
| Sep 25 | 112.45 | 109.68 | 116.36 | 6.09 |
| Sep 26 | 117.44 | 112.51 | 120.40 | 7.01 |
| Sep 27 | 115.82 | 113.39 | 120.41 | 6.19 |
| Sep 28 | 117.70 | 113.04 | 120.66 | 6.75 |
| Sep 29 | 119.53 | 117.17 | 122.83 | 4.84 |
| Sep 30 | 123.98 | 119.74 | 127.85 | 6.77 |
| Oct 01 | 124.95 | 120.75 | 130.79 | 8.32 |
| Oct 02 | 117.67 | 112.59 | 119.09 | 5.77 |
| Oct 03 | 120.92 | 116.06 | 124.19 | 7.00 |
| Oct 04 | 125.27 | 120.84 | 131.06 | 8.46 |
| Oct 05 | 128.96 | 125.63 | 133.52 | 6.28 |
| Oct 06 | 126.71 | 123.60 | 131.58 | 6.46 |
| Oct 07 | 132.87 | 127.37 | 134.63 | 5.70 |
| Oct 08 | 133.75 | 130.62 | 136.80 | 4.73 |
| Oct 09 | 135.27 | 129.51 | 140.55 | 8.52 |
| Oct 10 | 127.64 | 124.81 | 130.33 | 4.42 |
| Oct 11 | 123.28 | 120.69 | 128.31 | 6.31 |
| Oct 12 | 120.84 | 116.27 | 122.87 | 5.67 |
| Oct 13 | 122.00 | 120.17 | 127.20 | 5.85 |
| Oct 14 | 126.10 | 121.48 | 131.24 | 8.03 |
| Oct 15 | 133.66 | 130.21 | 139.84 | 7.39 |
| Oct 16 | 139.76 | 137.24 | 142.53 | 3.85 |
| Oct 17 | 147.64 | 141.17 | 152.60 | 8.10 |
| Oct 18 | 145.43 | 142.90 | 147.35 | 3.11 |
| Oct 19 | 146.47 | 143.40 | 152.54 | 6.37 |
| Oct 20 | 148.76 | 145.81 | 154.92 | 6.24 |
| Oct 21 | 146.71 | 141.60 | 152.43 | 7.65 |
BioNTech Daily Price Targets
BioNTech Stock Forecast 09-22-2024.
Forecast target price for 09-22-2024: $120.30.
Positive dynamics for BioNTech shares will prevail with possible volatility of 7.859%.
Pessimistic target level: 115.10
Optimistic target level: 124.92
BioNTech Stock Forecast 09-23-2024.
Forecast target price for 09-23-2024: $117.27.
Negative dynamics for BioNTech shares will prevail with possible volatility of 6.765%.
Pessimistic target level: 112.48
Optimistic target level: 120.65
BioNTech Stock Forecast 09-24-2024.
Forecast target price for 09-24-2024: $110.66.
Negative dynamics for BioNTech shares will prevail with possible volatility of 5.267%.
Pessimistic target level: 106.27
Optimistic target level: 112.18
BioNTech Stock Forecast 09-25-2024.
Forecast target price for 09-25-2024: $112.45.
Positive dynamics for BioNTech shares will prevail with possible volatility of 5.740%.
Pessimistic target level: 109.68
Optimistic target level: 116.36
BioNTech Stock Forecast 09-26-2024.
Forecast target price for 09-26-2024: $117.44.
Positive dynamics for BioNTech shares will prevail with possible volatility of 6.555%.
Pessimistic target level: 112.51
Optimistic target level: 120.40
BioNTech Stock Forecast 09-27-2024.
Forecast target price for 09-27-2024: $115.82.
Negative dynamics for BioNTech shares will prevail with possible volatility of 5.829%.
Pessimistic target level: 113.39
Optimistic target level: 120.41
BNTX (BNTX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 125.06 | 122.05 | 137.06 | 10.95 |
| Nov. | 130.16 | 125.78 | 133.59 | 5.85 |
| Dec. | 125.47 | 116.44 | 132.25 | 11.95 |
BioNTech forecast for this year
BioNTech Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $125.055. Pessimistic: $122.05. Optimistic: $137.06
BioNTech Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $130.157. Pessimistic: $125.78. Optimistic: $133.59
BioNTech Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $125.471. Pessimistic: $116.44. Optimistic: $132.25
BioNTech (BNTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 112.22 | 103.60 | 120.84 | 14.26 |
| Feb | 107.24 | 100.80 | 111.10 | 9.27 |
| Mar | 117.79 | 114.26 | 125.99 | 9.31 |
| Apr | 113.69 | 110.42 | 122.42 | 9.81 |
| May | 110.15 | 107.37 | 117.41 | 8.56 |
| Jun | 109.88 | 103.02 | 118.06 | 12.73 |
| Jul | 113.97 | 108.50 | 123.68 | 12.27 |
| Aug | 110.28 | 106.70 | 117.55 | 9.23 |
| Sep | 99.29 | 93.69 | 105.49 | 11.18 |
| Oct | 95.72 | 88.60 | 99.39 | 10.86 |
| Nov | 90.20 | 86.52 | 93.88 | 7.84 |
| Dec | 93.45 | 84.82 | 98.05 | 13.50 |
BioNTech (BNTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 98.05 | 88.64 | 103.70 | 14.52 |
| Feb | 94.40 | 87.72 | 98.82 | 11.23 |
| Mar | 99.95 | 94.32 | 102.83 | 8.28 |
| Apr | 101.99 | 97.95 | 107.38 | 8.78 |
| May | 103.46 | 95.89 | 107.81 | 11.06 |
| Jun | 102.34 | 99.52 | 108.24 | 8.06 |
| Jul | 98.54 | 91.20 | 106.34 | 14.23 |
| Aug | 94.75 | 92.25 | 100.67 | 8.36 |
| Sep | 105.10 | 101.32 | 113.30 | 10.58 |
| Oct | 106.61 | 102.01 | 113.91 | 10.45 |
| Nov | 106.23 | 98.58 | 113.24 | 12.95 |
| Dec | 103.81 | 100.94 | 113.27 | 10.89 |
BioNTech information and performance
AN DER GOLDGRUBE 12, MAINZ, DE
Market capitalization of the BioNTech SE is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BNTX shares in the company outstanding by the market price of one share.
EBITDA of BioNTech is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
BioNTech (BNTX) stock dividend
BioNTech last paid dividends on 06/02/2022. The next scheduled payment will be on 06/17/2022. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
